Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Drinabant> ?p ?o. }
Showing items 1 to 46 of
46
with 100 items per page.
- Drinabant abstract "Drinabant (INN; AVE-1625) is a drug that acts as a selective CB1 receptor antagonist, which was under investigation varyingly by Sanofi-Aventis as a treatment for obesity, schizophrenia, Alzheimer's disease, Parkinson's disease, and nicotine dependence. Though initially studied as a potential treatment for a variety of different medical conditions, Sanofi-Aventis eventually narrowed down the therapeutic indications of the compound to just appetite suppression. Drinabant reached phase IIb clinical trials for this purpose in the treatment of obesity but was shortly thereafter discontinued, likely due to the observation of severe psychiatric side effects including anxiety, depression, and thoughts of suicide in patients treated with the now-withdrawn rimonabant, another CB1 antagonist that was also under development by Sanofi-Aventis.".
- Drinabant atcPrefix "None".
- Drinabant casNumber "358970-97-5".
- Drinabant iupacName "(±)-N-{1-[bis(4-chlorophenyl)methyl]-3-azetidinyl}-N-(3,5-difluorophenyl)methanesulfonamide".
- Drinabant pubchem "10278470".
- Drinabant thumbnail Drinabant.svg?width=300.
- Drinabant wikiPageID "35805433".
- Drinabant wikiPageRevisionID "560778390".
- Drinabant atcPrefix "None".
- Drinabant c "23".
- Drinabant casNumber "358970".
- Drinabant chemspiderid "8453947".
- Drinabant cl "2".
- Drinabant f "2".
- Drinabant h "20".
- Drinabant hasPhotoCollection Drinabant.
- Drinabant inchi "1".
- Drinabant inchikey "IQQBRKLVEALROM-UHFFFAOYAF".
- Drinabant iupacName "-N-{1-[bismethyl]-3-azetidinyl}-N-methanesulfonamide".
- Drinabant molecularWeight "497.385".
- Drinabant n "2".
- Drinabant o "2".
- Drinabant pubchem "10278470".
- Drinabant s "1".
- Drinabant smiles "Fc1ccNSC".
- Drinabant stdinchi "1".
- Drinabant stdinchikey "IQQBRKLVEALROM-UHFFFAOYSA-N".
- Drinabant subject Category:Anorectics.
- Drinabant subject Category:Azetidines.
- Drinabant subject Category:CB1_receptor_antagonists.
- Drinabant subject Category:Cannabinoids.
- Drinabant subject Category:Organochlorides.
- Drinabant subject Category:Organofluorides.
- Drinabant subject Category:Sulfonamides.
- Drinabant type Drug.
- Drinabant type FunctionalSubstance.
- Drinabant comment "Drinabant (INN; AVE-1625) is a drug that acts as a selective CB1 receptor antagonist, which was under investigation varyingly by Sanofi-Aventis as a treatment for obesity, schizophrenia, Alzheimer's disease, Parkinson's disease, and nicotine dependence. Though initially studied as a potential treatment for a variety of different medical conditions, Sanofi-Aventis eventually narrowed down the therapeutic indications of the compound to just appetite suppression.".
- Drinabant label "Drinabant".
- Drinabant label "Drinabant".
- Drinabant sameAs Drinabant.
- Drinabant sameAs m.0jt0g5g.
- Drinabant sameAs Q5307675.
- Drinabant sameAs Q5307675.
- Drinabant wasDerivedFrom Drinabant?oldid=560778390.
- Drinabant depiction Drinabant.svg.
- Drinabant isPrimaryTopicOf Drinabant.
